( September 30, 2026, 1:49 PM EDT) -- SHERMAN, Texas — Novo Nordisk Inc. is seeking a permanent injunction barring a compounding pharmacy from selling certain compounded semaglutide products, alleging in an amended complaint filed in a Texas federal court that the pharmacy gains an unfair competitive advantage by selling drugs that have not received U.S. Food and Drug Administration approval....